Therefore, HMGR has become an important drug target in the treatment of hypercholesterolemia (Grundy et al., 2019), cardiovascular diseases (Zhou and Liao, 2009), and cancer (Jung et al., 2021). Here, HMGA1 is linked to familial hypercholesterolemia.